n
a
v
Portfolio
Genetics
AmplideX® mPCR FMR1 Kit
AmplideX® PCR/CE FMR1 Kit
AmplideX® FMR1 Controls
Xpansion Interpreter®
AmplideX® PCR/CE
SMN1/2
Plus Kit
AmplideX® PCR/CE
CFTR
Kit
AmplideX® PCR/CE C9orf72 Kit
AmplideX® PCR/CE
DMPK
Kit
AmplideX® PCR/CE
HTT
Kit
AmplideX® TRIO
Oncology
QuantideX® qPCR BCR-ABL IS Kit
QuantideX® qPCR BCR-ABL minor Kit
QuantideX® qPCR
ESR1
exoMutation Kit [Coming Soon]
QuantideX® qPCR PML-RARA Kit* [Coming Soon]
MolecularDx Controls
Catalog of Armored Products
SARS CoV-2 Controls
Made-To-Order Armored and Nucleic Acid
Molecular Assay Reagents
Custom & Companion Diagnostics
Partnered R&D
CAP-Accredited CLIA Lab
CTA Testing Site
Validated Platforms & Assays
Companion Diagnostics
Enabling Technologies
Assay Chemistries
Bioinformatics
Product Development Process
Resources
Publications
Articles
Whitepapers
Posters
Disease Information
Fragile X Syndrome
Dementia
Chronic Myeloid Leukemia (CML)
Other Resources
Videos
Carrier Screening Guide
Safety Data Sheets
Sales Contacts
Our Culture
Employee Spotlights
Culture & Heritage
Sales Contacts
Contact
EMEA
About
Leadership Team
Culture and Heritage
News
Upcoming Events
Business Development
Careers
Search
News
Home
News
Press Releases
Year
Select Year
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
February 10, 2016
Asuragen Names Colin Hill Senior Vice President of Commercial Operations
Share
December 5, 2015
Asuragen Launches AmplideX® PCR/CE FMR1 Reporter*, a Fully Automated Software Solution for Accurate Sizing of the FMR1 CGG Repeat Region
Share
November 3, 2015
Asuragen to Present at Upcoming 2015 Association for Molecular Pathology Annual Meeting in Austin, TX
Share
September 9, 2015
Asuragen to Collaborate with Illumina on Companion Diagnostics Development
Share
July 8, 2015
Asuragen Launches the QuantideX® NGS Pan Cancer Kit*, a Workflow Solution for Targeted Next-Generation Sequencing
Share
June 11, 2015
Asuragen Announces Launch of Highly Sensitive CE-IVD BCR-ABL Assay at the European Hematology Association Annual Congress
Share
March 24, 2015
Asuragen to present innovations in fragile X testing at upcoming American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
Share
January 12, 2015
Asuragen to join leading UK cancer research consortium to develop miRNA based sequencing tests for early detection and screening of cancer
Share
November 11, 2014
Asuragen Launches the QuantideX® qPCR DNA QC Assay to Improve the Accuracy of Next-Generation Sequencing
Share
October 5, 2014
Asuragen to present at upcoming Association for Molecular Pathology Annual Meeting in National Harbor, MD
Share
Prev
1
…
3
4
5
6
7
8
Next
About
About
Leadership Team
Culture and Heritage
News
Upcoming Events
Business Development
Back To
Top